Wolverine Trading’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-895
Closed -$7.82K 5282
2024
Q3
$9.03K Buy
+895
New +$14.9K ﹤0.01% 4688
2024
Q2
Sell
-973
Closed -$19.5K 4503
2024
Q1
$24.9K Sell
973
-1,295
-57% -$33.2K ﹤0.01% 4323
2023
Q4
$62.6K Buy
2,268
+1,010
+80% +$61.6K ﹤0.01% 4207
2023
Q3
$76.5K Buy
1,258
+279
+28% +$19.6K ﹤0.01% 4075
2023
Q2
$63K Sell
979
-197
-17% -$14.4K ﹤0.01% 3892
2023
Q1
$74K Buy
1,176
+564
+92% +$64.4K ﹤0.01% 3736
2022
Q4
$85K Buy
612
+60
+11% +$8.45K ﹤0.01% 3448
2022
Q3
$63K Buy
+552
New +$62.5K ﹤0.01% 4075
2022
Q2
Sell
-1,730
Closed -$171K 4532
2022
Q1
$171K Buy
+1,730
New +$228K ﹤0.01% 4515
2021
Q4
Sell
-808
Closed -$199K 5905
2021
Q3
$199K Sell
808
-904
-53% -$258K ﹤0.01% 5356
2021
Q2
$667K Sell
1,712
-2,820
-62% -$1.12M ﹤0.01% 3292
2021
Q1
$1.68M Buy
+4,532
New +$2.23M ﹤0.01% 2122
2020
Q4
Sell
-1,002
Closed -$635K 4815
2020
Q3
$714K Sell
1,002
-261
-21% -$204K ﹤0.01% 2415
2020
Q2
$983K Buy
1,263
+534
+73% +$403K ﹤0.01% 2018
2020
Q1
$443K Buy
+729
New +$710K ﹤0.01% 2788
2019
Q4
Sell
-821
Closed -$892K 4653
2019
Q3
$987K Sell
821
-5
-0.6% -$7.64K ﹤0.01% 2005
2019
Q2
$1.36M Buy
+826
New +$1.43M ﹤0.01% 1792
2018
Q4
Sell
-2,074
Closed -$3.92M 4438
2018
Q3
$3.92M Buy
2,074
+1,060
+105% +$2.19M 0.01% 1138
2018
Q2
$2.24M Hold
1,014
0.01% 1497
2018
Q1
$2.24M Sell
1,014
-942
-48% -$2.4M 0.01% 1497
2017
Q4
$4.51M Buy
1,956
+1,667
+577% +$3.38M 0.02% 932
2017
Q3
$515K Buy
+289
New +$404K ﹤0.01% 2569

Other funds holding BLUE

Wolverine Trading's BLUE Position: Q4 2024 in Review

Wolverine Trading sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 895 shares — an estimated $7.82K sold.

Wolverine Trading first reported a position in BLUE in Q3 2017 and held it in 22 quarters. The position peaked at $4.51M in Q4 2017. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Wolverine Trading reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 895 bluebird bio shares in Q4 2024, an estimated $7.82K.
  • Wolverine Trading first reported a position in bluebird bio in Q3 2017 and held it in 22 quarters.
  • Wolverine Trading's bluebird bio position peaked at $4.51M in Q4 2017.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.